A20 Promotes Glioma Stem Cell Mediated Tumorigenesis

A20 促进神经胶质瘤干细胞介导的肿瘤发生

基本信息

项目摘要

PROJECT SUMMARY Glioblastomas are the most common and aggressive primary brain tumor in adults, with a median survival of only fourteen months with the best available treatments. Much needed novel therapies may arise from increased appreciation of the biological and molecular properties of subset of tumor cells which can self-renew and recapitulate the parental tumor. These cancer stem cells remain controversial due to the evolving understanding of their nature: however, a number of reports have demonstrated that glioblastomas contain cancer stem cells and that these glioma stem cells contribute to therapeutic resistance and tumor angiogenesis. We now demonstrate that the cell survival regulator A20/Tumor Necrosis Factor a Inducible Protein 3 is a glioma stem cell target which contributes to glioma growth. Although very limited and often contradictory data exists regarding the expression and function of A20 in brain tumors, we find that GSCs consistently express elevated levels of A20 in comparison to non-stem glioma cells. Targeting the expression of A20 in GSCs reduces their growth in association with increased cell cycle arrest, elevated apoptosis, and decreased self-renewal. Targeting A20 in GSCs increased the survival of mice bearing human glioma xenografts, and analysis of a glioma expression database indicates that increased A20 mRNA correlates with poor glioma patient survival. Based on this background, we hypothesize that A20 promotes glioma growth and recurrence due, in part, to maintenance of a cancer stem cell phenotype. We propose to elucidate the molecular and biological role of A20 in glioma stem cell biology in an effort to determine novel targets for glioma patient therapies.
项目摘要 胶质母细胞瘤是成人中最常见和最具侵袭性的原发性脑肿瘤, 最佳治疗的中位生存期只有14个月。多 所需的新疗法可能来自对生物学和生物学特性的日益认识, 肿瘤细胞亚群的分子特性,可以自我更新和重演, 亲代肿瘤这些癌症干细胞仍然存在争议,由于不断发展的 然而,一些报告表明, 胶质母细胞瘤含有癌症干细胞,这些胶质瘤干细胞有助于 治疗抗性和肿瘤血管生成。我们现在证明细胞 生存调节因子A20/肿瘤坏死因子a诱导蛋白3是胶质瘤干细胞 有助于胶质瘤生长的靶点。虽然非常有限而且常常是矛盾的 关于A20在脑肿瘤中的表达和功能,我们发现, 与非干细胞胶质瘤相比,GSC始终表达升高水平的A20 细胞靶向GSC中A20的表达降低了它们的生长, 细胞周期停滞增加、凋亡增加和自我更新减少。靶向 GSC中的A20增加了携带人胶质瘤异种移植物的小鼠的存活率, 对神经胶质瘤表达数据库的分析表明,A20 mRNA的增加与神经胶质瘤的发生有关。 神经胶质瘤患者的存活率很低基于这一背景,我们假设A20 促进神经胶质瘤生长和复发,部分原因是维持癌干 细胞表型我们建议阐明A20的分子和生物学作用, 神经胶质瘤干细胞生物学为神经胶质瘤患者确定新靶点 治疗

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.
  • DOI:
    10.1101/gad.235515.113
  • 发表时间:
    2014-05-15
  • 期刊:
  • 影响因子:
    10.5
  • 作者:
    Yan K;Wu Q;Yan DH;Lee CH;Rahim N;Tritschler I;DeVecchio J;Kalady MF;Hjelmeland AB;Rich JN
  • 通讯作者:
    Rich JN
Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
  • DOI:
    10.1093/neuonc/nou320
  • 发表时间:
    2015-03
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Kevin Stoltz;M. Sinyuk;J. Hale;Qiulian Wu;B. Otvos;Kiera Walker;A. Vasanji;J. Rich;A. Hjelmeland;J. Lathia
  • 通讯作者:
    Kevin Stoltz;M. Sinyuk;J. Hale;Qiulian Wu;B. Otvos;Kiera Walker;A. Vasanji;J. Rich;A. Hjelmeland;J. Lathia
Method for Efficient Transduction of Cancer Stem Cells.
癌症干细胞的有效转导方法。
  • DOI:
    10.14343/jcscr.2014.2e1008
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Walker,Kiera;Hjelmeland,Anita
  • 通讯作者:
    Hjelmeland,Anita
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anita Borton Hjelmeland其他文献

Anita Borton Hjelmeland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anita Borton Hjelmeland', 18)}}的其他基金

Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus
靶向酸性神经酰胺酶提高疱疹溶瘤病毒的功效
  • 批准号:
    10841767
  • 财政年份:
    2022
  • 资助金额:
    $ 22.96万
  • 项目类别:
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells
唾液酸化在神经干细胞样脑肿瘤细胞的维持和代谢可塑性中的作用
  • 批准号:
    10538769
  • 财政年份:
    2022
  • 资助金额:
    $ 22.96万
  • 项目类别:
Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus
靶向酸性神经酰胺酶提高疱疹溶瘤病毒的功效
  • 批准号:
    10509476
  • 财政年份:
    2022
  • 资助金额:
    $ 22.96万
  • 项目类别:
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells
唾液酸化在神经干细胞样脑肿瘤细胞的维持和代谢可塑性中的作用
  • 批准号:
    10676849
  • 财政年份:
    2022
  • 资助金额:
    $ 22.96万
  • 项目类别:
Novel Mouse Models to Understand ST6Gal1-Mediated Sialylation Effects in the Developing and Pathologic Brain
研究发育中和病理性大脑中 ST6Gal1 介导的唾液酸化作用的新型小鼠模型
  • 批准号:
    10353267
  • 财政年份:
    2021
  • 资助金额:
    $ 22.96万
  • 项目类别:
Biosynthetic Metabolic Pathway Regulation of Glioma Growth
神经胶质瘤生长的生物合成代谢途径调节
  • 批准号:
    10057274
  • 财政年份:
    2017
  • 资助金额:
    $ 22.96万
  • 项目类别:
Biosynthetic Metabolic Pathway Regulation of Glioma Growth
神经胶质瘤生长的生物合成代谢途径调节
  • 批准号:
    10308389
  • 财政年份:
    2017
  • 资助金额:
    $ 22.96万
  • 项目类别:
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
A20 促进神经胶质瘤干细胞介导的肿瘤发生
  • 批准号:
    8100319
  • 财政年份:
    2010
  • 资助金额:
    $ 22.96万
  • 项目类别:
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
A20 促进神经胶质瘤干细胞介导的肿瘤发生
  • 批准号:
    8494594
  • 财政年份:
    2010
  • 资助金额:
    $ 22.96万
  • 项目类别:
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
A20 促进神经胶质瘤干细胞介导的肿瘤发生
  • 批准号:
    8288833
  • 财政年份:
    2010
  • 资助金额:
    $ 22.96万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 22.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了